Quantification of three-dimensional structures in liver tissue by Ahmed, Hassan et al.
EXCLI Journal 2014;13:548-550 – ISSN 1611-2156 
Received: April 28, 2014, accepted: May 08, 2014, published: May 19, 2014 
 
 
548 
Letter to the editor: 
QUANTIFICATION OF THREE-DIMENSIONAL STRUCTURES  
IN LIVER TISSUE: BILE CANALICULAR  
AND SINUSOIDAL NETWORKS 
 
Hassan Ahmed1,*, Mosaab A. Omar2, Ahmed M. Abdou3 
 
Faculty of Veterinary Medicine, South Valley University, 83523 Qena, Egypt 
1 Department of Physiology 
2 Department of Parasitology 
3 Department of Forensic Medicine and Veterinary Toxicology 
 
* Corresponding author: Dr. Hassan Ahmed, Department of Physiology, Faculty of Veterinary 
Medicine, South Valley University, 83523 Qena, Egypt 
 E-mail: hassan-younes@vet.svu.edu.eg 
 
 
Dear Editor, 
Unpredicted hepatotoxicity represents the most frequent reason for withdrawal of drugs 
from the market (Godoy et al., 2013). Therefore, large efforts are currently undertaken to 
establish improved techniques to predict hepatotoxicity (Shimizu et al., 2009; O’Brien et al., 
2006; Okwa et al., 2013; Oloyede et al., 2013; Lu et al., 2013; Godoy et al., 2009). The 
perhaps most intensive activities in this field of research can be observed in establishment of 
hepatocyte in vitro systems (Godoy et al., 2013; Hewitt et al., 2007; Ilkavets et al., 2013; 
Hengstler et al., 2012, 2014; Hammad et al., 2013; Hammad, 2013). One of the concepts of 
this type of in vitro research is that stress responses to chemicals are similar in vitro and in 
vivo. Therefore, activation of stress response pathways in vitro may indicate a potential hazard 
(Jennings, 2013; Vinken et al., 2014). Although hepatocyte in vitro systems have promoted 
our understanding of mechanisms (Meyer et al., 2011; Schug et al., 2013; Godoy et al., 2010, 
2012; Zellmer et al., 2010; Hengstler et al., 2014) it has also become clear that a full 
replacement of animal experiments for toxicity testing will not be possible within the next one 
or two decades (Adler et al., 2011; Hammad, 2013). Reasons are difficulties to include 
xenobiotic metabolism into in vitro tests, to model interactions between cell types, to 
extrapolate from in vivo doses to in vitro concentrations and to simulate the consequences of 
long term exposure in vitro (Tice et al., 2013; Ghallab, 2013). However, one additional aspect 
may currently be underestimated: we still know too little about mechanisms of in vivo toxicity 
to establish in vitro systems in a way that the most critical in vivo processes are recapitulated. 
Although this may seem paradoxical, progress in replacement of animal experiments currently 
depends on progress in understanding the mechanisms of toxicity in vivo.  
Histological alterations often constitute a fingerprint of toxic mechanisms (Hammad et al., 
2014). Particularly, liver toxicity often leads to altered tissue microarchitecture (Höhme et al., 
2007; Hoehme et al., 2010; Braeuning et al., 2010; Schreiber et al., 2011). Moreover, current 
studies on liver histology largely rely on image analysis of two-dimensional pictures. 
However, many aspects of liver tissue architecture such as the complex bile canalicular and 
sinusoidal networks can be much better quantified using three-dimensional reconstructions. In 
this context, it represents an important step forward that Dr. Hammad and his team have 
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established a technique for staining, three-dimensional reconstruction and quantification of 
liver microarchitecture (Hammad et al., 2014). These protocols which can be applied under 
routine conditions allow: (1) the simultaneous staining of bile canalicular and sinusoidal 
networks in approximately 100 µm thick liver tissue blocks; (2) identification of S-phase 
positive cells whereby the position, size and shape of all individual cells is robustly captured; 
(3) quantification of key parameters such as hepatocyte volume, the fraction of hepatocytes in 
contact with neighboring hepatocytes, sinusoids and bile canaliculi. Parameters of the bile 
canalicular network include the length and branching angles of individual canaliculi, the 
number of dead end branches and the length of canaliculi per tissue volume. Further, 
parameters that can be quantified are the radius of the sinusoids, percentage of vessel volume 
in relation to tissue volume, the branching angle and the length of intersection branches of 
sinusoids. 
Briefly, key parameters of liver tissue microarchitecture can now be quantified routinely. 
It can be expected that the novel technique will lead to a more precise and robust 
characterization of hepatotoxicity. 
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